Downregulation of antigen-presenting cell functions after administration of mitogenic anti-CD3 monoclonal antibodies in mice.
暂无分享,去创建一个
M. Goldman | K. Wissing | M. Moser | F. Andris | O. Leo | E. Muraille | M. Alegre | B. Pajak | J. Urbain | T. de Smedt | F. Desalle
[1] D. Abramowicz,et al. Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice. , 1999, Transplantation.
[2] M. Moser,et al. Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. , 1998, Journal of immunology.
[3] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[4] D. Hart,et al. Dendritic cells: unique leukocyte populations which control the primary immune response. , 1997, Blood.
[5] Francesca Granucci,et al. Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures , 1997, The Journal of experimental medicine.
[6] P. De Baetselier,et al. Regulation of Dendritic Cell Numbers and Maturation by Lipopolysaccharide in Vivo , 1996 .
[7] P. Linsley,et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways , 1996, Nature.
[8] A. Enk,et al. Interleukin‐12 is produced by dendritic cells and mediates T helper 1 development as well as interferon‐γ production by T helper 1 cells , 1996, European journal of immunology.
[9] J. Bluestone,et al. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells. , 1996, Transplantation.
[10] K. Murphy,et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation , 1996, The Journal of experimental medicine.
[11] G. Opelz. EFFICACY OF REJECTION PROPHYLAXIS WITH OKT3 IN RENAL TRANSPLANTATION , 1995, Transplantation.
[12] M. Moser,et al. Glucocorticoids down‐regulate dendritic cell function in vitro and in vivo , 1995, European journal of immunology.
[13] D. Abramowicz,et al. The induction of human T cell unresponsiveness by soluble anti-CD3 mAb requires T cell activation. , 1995, International immunology.
[14] J. Bluestone,et al. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity. , 1995, Journal of immunology.
[15] P. Morris,et al. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1 , 1995, The Journal of experimental medicine.
[16] G. Trinchieri,et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. , 1995, Journal of immunology.
[17] G. Trinchieri,et al. Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in mice , 1995, European journal of immunology.
[18] G. Trinchieri,et al. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Steinman,et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro , 1994, The Journal of experimental medicine.
[20] P. Vandenabeele,et al. In vivo immunosuppression induced by a weakly mitogenic antibody to mouse CD3: evidence that induction of long-lasting in vivo unresponsiveness requires TcR signaling. , 1994, Cellular immunology.
[21] E. Clark,et al. Properties of mouse CD40: Cellular distribution of CD40 and B cell activation by monoclonal anti‐mouse CD40 antibodies , 1994, European journal of immunology.
[22] P. Morris,et al. Isolation and characterization of dendritic cells from mouse heart and kidney. , 1994, Journal of immunology.
[23] J. Siegel,et al. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. , 1993, Journal of immunology.
[24] L. Chatenoud. Humoral immune response against OKT3. , 1993, Transplantation proceedings.
[25] P. Vereerstraeten,et al. THE LONG‐TERM EFFECTS OF PROPHYLACTIC OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY TRANSPLANTATION—A SINGLE‐CENTER, PROSPECTIVE, RANDOMIZED STUDY , 1992, Transplantation.
[26] P. Linsley,et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. , 1992, Science.
[27] D. Abramowicz,et al. The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes , 1992, The Journal of experimental medicine.
[28] M. Moser,et al. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo , 1992, The Journal of experimental medicine.
[29] L. Chatenoud,et al. OKT3 in organ transplantation , 1991 .
[30] R. Gress,et al. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction. , 1991, Journal of immunology.
[31] T. Gajewski,et al. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. , 1991, Journal of immunology.
[32] R. Steinman,et al. Migration and maturation of Langerhans cells in skin transplants and explants , 1990, The Journal of experimental medicine.
[33] S. Knight,et al. LOW‐DOSE IMMUNOSUPPRESSION BY CYCLOSPORINE OPERATING VIA ANTIGEN‐PRESENTING DENDRITIC CELLS , 1990, Transplantation.
[34] J. Bluestone,et al. Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. , 1990, Transplantation.
[35] K. Gilbert,et al. Th1 and Th2 clones differ in their response to a tolerogenic signal. , 1990, Journal of immunology.
[36] M. Strate,et al. First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization. , 1990, Transplantation proceedings.
[37] P. Morris,et al. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection , 1990, The Journal of experimental medicine.
[38] P. Vereerstraeten,et al. RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN‐2, AND GAMMA‐INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS , 1989, Transplantation.
[39] J. Whelchel,et al. EFFICACY OF OKT3 MONOCLONAL ANTIBODY THERAPY IN STEROID‐RESISTANT, PREDOMINANTLY VASCULAR ACUTE REJECTION: A Report of three Cases with Morphologic and Immunophenotypic Evaluation , 1988, Transplantation.
[40] S. Knight,et al. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies , 1987, The Journal of experimental medicine.
[41] R. Schwartz,et al. The T lymphocyte response to cytochrome c. V. Determination of the minimal peptide size required for stimulation of T cell clones and assessment of the contribution of each residue beyond this size to antigenic potency. , 1985, Journal of immunology.
[42] J. McKenzie,et al. THE EFFECT OF DONOR PRETREATMENT ON INTERSTITIAL DENDRITIC CELL CONTENT AND RAT CARDIAC ALLOGRAFT SURVIVAL , 1984, Transplantation.
[43] J. McKenzie,et al. Depletion of donor kidney dendritic cells prolongs graft survival. , 1984, Transplantation proceedings.
[44] P. Marrack,et al. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody , 1983, The Journal of experimental medicine.
[45] J. Fabre,et al. Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain , 1981, The Journal of experimental medicine.
[46] E. Margoliash,et al. The T lymphocyte response to cytochrome c--II. Molecular characterization of a pigeon cytochrome c determinant recognized by proliferating T lymphocytes of the B10.A mouse. , 1980, Molecular immunology.
[47] J. Rees,et al. What injection? , 1997, British Dental Journal.
[48] C. Figdor,et al. Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3. , 1996, Blood.
[49] I. Roitt,et al. OKT3: Immunology, production, purification, and pharmacokinetics , 1993, Clinical Transplantation.
[50] O. Janssen,et al. Immunosuppression by OKT3--induction of programmed cell death (apoptosis) as a possible mechanism of action. , 1992, Transplantation.
[51] B. Julian,et al. OKT3 first-dose reaction: association with T cell subsets and cytokine release. , 1991, Kidney international.
[52] C. Ferran,et al. The anti-CD3-induced syndrome: a consequence of massive in vivo cell activation. , 1991, Current topics in microbiology and immunology.
[53] L. Chatenoud,et al. The OKT3 immunosuppressive effect. In situ antigenic modulation of human graft-infiltrating T cells. , 1990, Transplantation.
[54] A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. , 1985, The New England journal of medicine.
[55] P. Marrack,et al. The major histocompatibility complex-restricted antigen receptor on T cells. , 1984, Annual review of immunology.